During a Feb. 6 fourth-quarter earnings call with investors, Cigna CEO David Cordani said the litigation with Anthem is “on course to resolve itself by the end of this calendar month.” According to a transcript of the call, Mr. Cordani said, “We feel very strong about our position relative to our contractual responsibility and contractual ability to collect our break fee.”
In 2015, Anthem extended an offer to acquire Cigna in a $48.9 billion cash and stock deal. However, the deal ended two years later due to antitrust concerns. A trial over who should pay the breakup fee began in February 2019.
More articles on payers:
CMS releases proposed Medicare Advantage rule: 5 things to know
10 largest health insurers
Humana, PE firm bet $600M on Medicare clinics: 5 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
